ReviewFrontiers in cardiovascular medicine2026
Risk factors for atrial fibrillation after lung cancer surgery: a meta-analysis.
Review in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Incidence of new-onset atrial fibrillation after thoracic radiotherapy in non-small cell lung cancer: a systematic review and meta-analysis.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study aims to explore potential risk factors for atrial fibrillation (AF) following lung cancer surgery through a meta-analysis. Methods: PubMed, Embase, and the Cochrane Library databases were searched to identify all relevant studies on postoperative AF following lung cancer surgery. Inclusion criteria specified adult patients with lung cancer surgery who had clearly reported risk factors for AF. The search was conducted up to October 20, 2025. The quality of included studies was assessed using the standardized NOS scoring tool, and statistical analysis was performed using Stata 15. Data from all included studies were analyzed using a random-effects model. Results: A total of 13 articles involving 20,701 lung cancer patients were included. The meta-analysis results suggest that age >65[OR = 1.68, 95% CI (1.30, 2.16)], Postoperative high BNP [OR = 3.82, 95% CI (1.43, 10.25)], male [OR = 1.82, 95% CI (1.35, 2.45)], smoking [OR = 1.72, 95% CI (1.35, 2.21)], hypertension [OR = 1.63, 95% CI (1.08, 2.48)], patients with TNM stage II lung cancer [OR = 2.21, 95% CI (1.22, 4.01)], transfusion [OR = 3.74, 95% CI (2.28, 6.12)] were associated with an increased risk of postoperative AF after lung cancer surgery. Conclusions: This study suggesting that factors such as age >65 years, male gender, smoking, hypertension, elevated postoperative BNP levels, TNM stage II, and perioperative blood transfusion may be associated with an increased risk of postoperative AF in lung cancer patients. Systematic Review Registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD420251176315, Prospero CRD420251176315.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.